Concepedia

Tarah J. Ballinger

TJ

Statistics

Publications

25

Citations

1.4K

H-Index

16

Active since

2014

Affiliations

Indiana University – Purdue University Indianapolis(Current)

University of Pennsylvania

Indiana University School of Medicine

Georgetown University

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Tarah J. Ballinger is an author at Indiana University – Purdue University Indianapolis specializing in oncology, medicine, and molecular oncology.

Publications per year

2014–2025

25

Publications

25

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Nadine Tung, Mark E. Robson, Steffen Ventz et al. · Journal of Clinical Oncology · 2020 · 500 citations

Medicine, Oncology, Pharmacology +16

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

Milan Radovich, Guanglong Jiang, Bradley A. Hancock et al. · JAMA Oncology · 2020 · 302 citations · Full text

Medicine, Oncology, Breast Oncology +16

Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer

Samilia Obeng‐Gyasi, Mohamed I. Elsaid, Yurong Lu et al. · JAMA Network Open · 2023 · 72 citations · Full text

Medicine, Biostatistics, Oncology +13

NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

Brandie C. Taylor, Xiaopeng Sun, Paula I. González-Ericsson et al. · Cancer Discovery · 2023 · 63 citations · Full text

Life Sciences, Immunology, Oncology +17

TBCRC 048: A phase II study of olaparib monotherapy in metastatic breast cancer patients with germline or somatic mutations in DNA damage response (DDR) pathway genes (Olaparib Expanded).

Nadine Tung, Mark E. Robson, Steffen Ventz et al. · Journal of Clinical Oncology · 2020 · 60 citations

Medicine, Oncology, Pharmacology +16

1–5 of 25